Alnylam Pharmaceuticals
ALNY
#535
Rank
ยฃ33.32 B
Marketcap
ยฃ252.23
Share price
1.58%
Change (1 day)
12.93%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company